Trial REDEFINE 3 (ongoing) Phase 3 Duration Event-driven Population (N) Adults with cardiovascular disease Key Result Cardiovascular outcomes readout pending
TB-500 for Cardiovascular Health Preliminary studies suggest that TB-500 may have positive effects on cardiovascular health
Reliable after-sales support throughout the cooperation
If you cannot use all the reconstituted DSIP within a month, consider smaller vial sizes or split your reconstitution to maintain fresh supply
Whether applied to studies of aging biology, exercise physiology, cancer metabolism, or fundamental cellular energetics, 5-amino-1MQ provides the precision and reliability required for advancing our understanding of how metabolic networks integrate to maintain cellular and organismal health
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors